SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

BrightSpring Health Services, Inc. (BTSG) News

Track canonical SquawkNews coverage tagged to BTSG, BrightSpring Health Services, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol BTSG Asset equity Sector Markets 90 days 7 Last 59.695 Updated Jul 31, 2026, 02:23 PM UTC Open live news feed
L BrightSpring Health Services shares are trading lower despite reporting better-than-expected Q2 financial results and raising its FY26 sales BrightSpring Health Services shares are trading lower despite reporting better-than-expected Q2 financial results and raising its FY26 sales guidance above estimates. The stock has gained over 600% in two years. EARNINGS | Jul 31, 2026, 02:23 PM UTC L BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B Est BrightSpring Health (NASDAQ: BTSG ) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate. EARNINGS | Jul 31, 2026, 10:01 AM UTC L BTSG - BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance - Click For Re BTSG - BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance EARNINGS | Jul 31, 2026, 10:00 AM UTC L American Express, Biogen upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: JPMorgan upgraded American Express EQUITY | Jul 13, 2026, 01:43 PM UTC L B of A Securities Maintains Buy on BrightSpring Health, Raises Price Target to $77 B of A Securities analyst Kevin Fischbeck maintains BrightSpring Health (NASDAQ: BTSG ) with a Buy and raises the price target from $66 to $77. EQUITY | Jul 02, 2026, 02:45 PM UTC H MU Price Target Raised Needham raises Micron Technology price target from $500 to $1,550 and maintains Buy rating EQUITY | Jun 22, 2026, 01:03 PM UTC M BTSG: BTIG Raises PT BTIG maintains buy rating on BrightSpring Health and raises price target to $90 EQUITY | Jun 22, 2026, 12:40 PM UTC